Essays about: "pharmaceutical patents"
Showing result 16 - 20 of 40 essays containing the words pharmaceutical patents.
-
16. Alternative legal incentives for antibiotic research and development : The role and function of legal mechanisms
University essay from Uppsala universitet/Juridiska institutionenAbstract : In Europe there are 25 000 deaths per year as a result of antimicrobial resistance and in the world the estimated annual number of deaths is 700 000. By 2050, it has been predicted that 10 million people per year could die from being resistant to antibiotic compounds. READ MORE
-
17. Using Compulsory Licenses to Facilitate Access to Medicines: The Indian Experience
University essay from Lunds universitet/Juridiska institutionenAbstract : The attempts to make use of a compulsory licensing provision under the TRIPS Agreement brought human rights, notably, the right to health, into the foreground of the debate between patents and access to medicines. This whole thesis is about the existing tensions between the two regimes – patents and human rights. READ MORE
-
18. Access to Medicines and Pharmaceutical Patents:Corporate Responsibility to Respect in the Pharmaceutical Industry
University essay from Lunds universitet/Juridiska institutionenAbstract : The U.N. Guiding Principles on Business and Human Rights is the final work of the meticulous mandate upheld by the Special Representative of the Secretary-General between 2005 and 2011. READ MORE
-
19. The role of TRIPS in health innovation and access to medicines in Brazil
University essay from Lunds universitet/Juridiska institutionenAbstract : The thesis undertakes an analysis of the current tension between patents law obligations under TRIPS Agreement and human rights, specifically in the context of how the TRIPS Agreement influences health innovation and access to medicines in Brazil. Following a general overview of the interaction between human rights and patent law within the WTO, the central aim is based on the empirical analysis of two Brazilian case studies: “Pharmaceutical Patents on Access to Medicines” and “ONSA Network’s Genoma Program”. READ MORE
-
20. The communicated CSR structure of AstraZeneca and Pfizer - and some reflective suggestions
University essay from Göteborgs universitet/Företagsekonomiska institutionenAbstract : Several patents of description drugs are running out and numerous cheaper generics copies threatens to take place on the market. In order to ensure quality of the products and low burden on the society, regarding environmental and social aspects, the pharmaceutical industry has to find new innovative products or to finding a way of keeping their stakeholders close. READ MORE